Celastrol combined with TNF-related apoptosis-inducing ligand (TRAIL/APO-2L) exerted strong synergistic antiproliferative effect against human cancer cells, including those from ovary cancer (OVCAR-8), colon cancer (SW620), and lung cancer (95-D). The gene discussed is TNFSF10; the disease is ovarian cancer.